{
  "input": {
    "mode": "score",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_mesalamine",
          "name": "Mesalamine"
        }
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_budesonide",
          "name": "Budesonide"
        }
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_prednisone",
          "name": "Prednisone"
        }
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        }
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_6_mercaptopurine",
          "name": "6-Mercaptopurine"
        }
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        }
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        }
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_ticagrelor",
          "name": "Ticagrelor"
        }
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        }
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_vedolizumab",
          "name": "Vedolizumab"
        }
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_tofacitinib",
          "name": "Tofacitinib"
        }
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_rifaximin",
          "name": "Rifaximin"
        }
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_mesalamine",
          "type": "Drug",
          "label": "Mesalamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_6_mercaptopurine",
          "type": "Drug",
          "label": "6-Mercaptopurine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ticagrelor",
          "type": "Drug",
          "label": "Ticagrelor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vedolizumab",
          "type": "Drug",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tofacitinib",
          "type": "Drug",
          "label": "Tofacitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rifaximin",
          "type": "Drug",
          "label": "Rifaximin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_epithelial_cells",
          "type": "Target",
          "label": "Epithelial Cells",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_inflammatory_response",
          "type": "Pathway",
          "label": "Inflammatory Response",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_gastrointestinal_disorders",
          "type": "Disease",
          "label": "Gastrointestinal Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_barrier_dysfunction",
          "type": "Phenotype",
          "label": "Barrier Dysfunction",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot_mesalamine",
          "type": "Target",
          "label": "Mesalamine Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_mesalamine",
          "type": "Pathway",
          "label": "Mesalamine Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_mesalamine",
          "type": "Phenotype",
          "label": "Adverse Effects of Mesalamine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_budesonide",
          "type": "Target",
          "label": "Budesonide Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_budesonide",
          "type": "Pathway",
          "label": "Budesonide Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_budesonide",
          "type": "Phenotype",
          "label": "Adverse Effects of Budesonide",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_prednisone",
          "type": "Target",
          "label": "Prednisone Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_prednisone",
          "type": "Pathway",
          "label": "Prednisone Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_prednisone",
          "type": "Phenotype",
          "label": "Adverse Effects of Prednisone",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_azathioprine",
          "type": "Target",
          "label": "Azathioprine Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_azathioprine",
          "type": "Pathway",
          "label": "Azathioprine Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_azathioprine",
          "type": "Phenotype",
          "label": "Adverse Effects of Azathioprine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_6mercaptopurine",
          "type": "Target",
          "label": "6-Mercaptopurine Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_6mercaptopurine",
          "type": "Pathway",
          "label": "6-Mercaptopurine Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_6mercaptopurine",
          "type": "Phenotype",
          "label": "Adverse Effects of 6-Mercaptopurine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_infliximab",
          "type": "Target",
          "label": "Infliximab Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_infliximab",
          "type": "Pathway",
          "label": "Infliximab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_infliximab",
          "type": "Phenotype",
          "label": "Adverse Effects of Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_adalimumab",
          "type": "Target",
          "label": "Adalimumab Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_adalimumab",
          "type": "Pathway",
          "label": "Adalimumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_adalimumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ticagrelor",
          "type": "Target",
          "label": "Ticagrelor Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ticagrelor",
          "type": "Pathway",
          "label": "Ticagrelor Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ticagrelor",
          "type": "Phenotype",
          "label": "Adverse Effects of Ticagrelor",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ustekinumab",
          "type": "Target",
          "label": "Ustekinumab Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ustekinumab",
          "type": "Pathway",
          "label": "Ustekinumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ustekinumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Ustekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_vedolizumab",
          "type": "Target",
          "label": "Vedolizumab Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_vedolizumab",
          "type": "Pathway",
          "label": "Vedolizumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_vedolizumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Vedolizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_tofacitinib",
          "type": "Target",
          "label": "Tofacitinib Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_tofacitinib",
          "type": "Pathway",
          "label": "Tofacitinib Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_tofacitinib",
          "type": "Phenotype",
          "label": "Adverse Effects of Tofacitinib",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_rifaximin",
          "type": "Target",
          "label": "Rifaximin Off-Target Effects",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_rifaximin",
          "type": "Pathway",
          "label": "Rifaximin Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_rifaximin",
          "type": "Phenotype",
          "label": "Adverse Effects of Rifaximin",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_mesalamine",
          "target": "target_epithelial_cells",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知靶向肠道上皮细胞"
        },
        {
          "source": "drug_budesonide",
          "target": "target_epithelial_cells",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "具有抗炎作用"
        },
        {
          "source": "drug_prednisone",
          "target": "target_epithelial_cells",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "类固醇类药物改善肠道损伤"
        },
        {
          "source": "drug_azathioprine",
          "target": "target_epithelial_cells",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "免疫抑制剂可以改善相关疾病"
        },
        {
          "source": "drug_6_mercaptopurine",
          "target": "target_epithelial_cells",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与多种肠道疾病相关临床应用"
        },
        {
          "source": "drug_infliximab",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "单克隆抗体调节炎症反应"
        },
        {
          "source": "drug_adalimumab",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "单克隆抗体也能影响炎症"
        },
        {
          "source": "drug_ticagrelor",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "尽管主要用于心血管，但可能影响其他通路"
        },
        {
          "source": "drug_ustekinumab",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "针对IL-12/23的作用"
        },
        {
          "source": "drug_vedolizumab",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "靶向肠道特异性强调"
        },
        {
          "source": "drug_tofacitinib",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "JAK抑制剂在免疫过程中的潜在应用"
        },
        {
          "source": "drug_rifaximin",
          "target": "pathway_inflammatory_response",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "影响肠道微生物与炎症"
        },
        {
          "source": "target_epithelial_cells",
          "target": "phenotype_barrier_dysfunction",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "上皮细胞功能直接影响屏障功能"
        },
        {
          "source": "pathway_inflammatory_response",
          "target": "disease_gastrointestinal_disorders",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与多种胃肠疾病相关的炎症通路"
        },
        {
          "source": "phenotype_barrier_dysfunction",
          "target": "disease_gastrointestinal_disorders",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "屏障功能障碍导致胃肠道疾病"
        },
        {
          "source": "drug_mesalamine",
          "target": "H1",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "有效改善肠道上皮障碍相关疾病"
        },
        {
          "source": "drug_budesonide",
          "target": "H2",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "临床实践中常用于肠道疾病"
        },
        {
          "source": "drug_prednisone",
          "target": "H3",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有效性通过临床观察得知"
        },
        {
          "source": "drug_azathioprine",
          "target": "H4",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "用药历史表明其对肠道疾病的影响"
        },
        {
          "source": "drug_6_mercaptopurine",
          "target": "H5",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "存在用于治疗溃疡性结肠炎等的依据"
        },
        {
          "source": "drug_infliximab",
          "target": "H6",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "众多临床试验支持其有效性"
        },
        {
          "source": "drug_adalimumab",
          "target": "H7",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "临床使用数据与疗效高度一致"
        },
        {
          "source": "drug_ustekinumab",
          "target": "H9",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "相关指引建议其用于治疗"
        },
        {
          "source": "drug_vedolizumab",
          "target": "H10",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "针对肠道特异性的临床证据支持"
        },
        {
          "source": "drug_tofacitinib",
          "target": "H11",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "存在潜在作用，但需更多研究"
        },
        {
          "source": "drug_rifaximin",
          "target": "H12",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "需要进一步验证其效果"
        },
        {
          "source": "drug_mesalamine",
          "target": "n_ot_mesalamine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶效应导致风险"
        },
        {
          "source": "n_ot_mesalamine",
          "target": "n_rp_mesalamine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_mesalamine",
          "target": "n_adv_mesalamine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良反应"
        },
        {
          "source": "n_adv_mesalamine",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如若风险成立，将抵消效益"
        },
        {
          "source": "drug_budesonide",
          "target": "n_ot_budesonide",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶效应导致风险"
        },
        {
          "source": "n_ot_budesonide",
          "target": "n_rp_budesonide",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_budesonide",
          "target": "n_adv_budesonide",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良反应"
        },
        {
          "source": "n_adv_budesonide",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如若风险成立，将抵消效益"
        },
        {
          "source": "drug_prednisone",
          "target": "n_ot_prednisone",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶效应导致风险"
        },
        {
          "source": "n_ot_prednisone",
          "target": "n_rp_prednisone",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_prednisone",
          "target": "n_adv_prednisone",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良反应"
        },
        {
          "source": "n_adv_prednisone",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如若风险成立，将抵消效益"
        },
        {
          "source": "drug_azathioprine",
          "target": "n_ot_azathioprine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶效应导致风险"
        },
        {
          "source": "n_ot_azathioprine",
          "target": "n_rp_azathioprine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_azathioprine",
          "target": "n_adv_azathioprine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良反应"
        },
        {
          "source": "n_adv_azathioprine",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如若风险成立，将抵消效益"
        },
        {
          "source": "drug_6_mercaptopurine",
          "target": "n_ot_6mercaptopurine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶效应导致风险"
        },
        {
          "source": "n_ot_6mercaptopurine",
          "target": "n_rp_6mercaptopurine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_6mercaptopurine",
          "target": "n_adv_6mercaptopurine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良反应"
        },
        {
          "source": "n_adv_6mercaptopurine",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如若风险成立，将抵消效益"
        },
        {
          "source": "drug_infliximab",
          "target": "n_ot_infliximab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶效应导致风险"
        },
        {
          "source": "n_ot_infliximab",
          "target": "n_rp_infliximab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_infliximab",
          "target": "n_adv_infliximab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良反应"
        },
        {
          "source": "n_adv_infliximab",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如若风险成立，将抵消效益"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_ot_adalimumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶效应导致风险"
        },
        {
          "source": "n_ot_adalimumab",
          "target": "n_rp_adalimumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_adalimumab",
          "target": "n_adv_adalimumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良反应"
        },
        {
          "source": "n_adv_adalimumab",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如若风险成立，将抵消效益"
        },
        {
          "source": "drug_ticagrelor",
          "target": "n_ot_ticagrelor",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶效应导致风险"
        },
        {
          "source": "n_ot_ticagrelor",
          "target": "n_rp_ticagrelor",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_ticagrelor",
          "target": "n_adv_ticagrelor",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良反应"
        },
        {
          "source": "n_adv_ticagrelor",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如若风险成立，将抵消效益"
        },
        {
          "source": "drug_ustekinumab",
          "target": "n_ot_ustekinumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶效应导致风险"
        },
        {
          "source": "n_ot_ustekinumab",
          "target": "n_rp_ustekinumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_ustekinumab",
          "target": "n_adv_ustekinumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良反应"
        },
        {
          "source": "n_adv_ustekinumab",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如若风险成立，将抵消效益"
        },
        {
          "source": "drug_vedolizumab",
          "target": "n_ot_vedolizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶效应导致风险"
        },
        {
          "source": "n_ot_vedolizumab",
          "target": "n_rp_vedolizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_vedolizumab",
          "target": "n_adv_vedolizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良反应"
        },
        {
          "source": "n_adv_vedolizumab",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如若风险成立，将抵消效益"
        },
        {
          "source": "drug_tofacitinib",
          "target": "n_ot_tofacitinib",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶效应导致风险"
        },
        {
          "source": "n_ot_tofacitinib",
          "target": "n_rp_tofacitinib",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_tofacitinib",
          "target": "n_adv_tofacitinib",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良反应"
        },
        {
          "source": "n_adv_tofacitinib",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如若风险成立，将抵消效益"
        },
        {
          "source": "drug_rifaximin",
          "target": "n_ot_rifaximin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶效应导致风险"
        },
        {
          "source": "n_ot_rifaximin",
          "target": "n_rp_rifaximin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "与风险通路相关"
        },
        {
          "source": "n_rp_rifaximin",
          "target": "n_adv_rifaximin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能造成不良反应"
        },
        {
          "source": "n_adv_rifaximin",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "如若风险成立，将抵消效益"
        }
      ],
      "round_index": 3
    },
    "history": {
      "round": 3,
      "last_scores": []
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "scoring_summary": [
      {
        "hypothesis_id": "H1",
        "score": 0.33,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.75
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "已知靶向肠道上皮细胞"
          ],
          "safety_risk": [
            "如若风险成立，将抵消效益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.33,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.75
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "具有抗炎作用"
          ],
          "safety_risk": [
            "如若风险成立，将抵消效益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.33,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.75
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "类固醇类药物改善肠道损伤"
          ],
          "safety_risk": [
            "如若风险成立，将抵消效益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.33,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.75
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "免疫抑制剂可以改善相关疾病"
          ],
          "safety_risk": [
            "如若风险成立，将抵消效益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.33,
        "components": {
          "mechanism_fit": 0.5,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.75
        },
        "graph_signals": {
          "support_weight": 0.65,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "与多种肠道疾病相关临床应用"
          ],
          "safety_risk": [
            "如若风险成立，将抵消效益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.33,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.75
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "单克隆抗体调节炎症反应"
          ],
          "safety_risk": [
            "如若风险成立，将抵消效益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H7",
        "score": 0.33,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.75
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "单克隆抗体也能影响炎症"
          ],
          "safety_risk": [
            "如若风险成立，将抵消效益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.13,
        "components": {
          "mechanism_fit": 0.3,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.3,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.85
        },
        "graph_signals": {
          "support_weight": 0.65,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "尽管主要用于心血管，但可能影响其他通路"
          ],
          "safety_risk": [
            "如若风险成立，将抵消效益"
          ]
        },
        "confidence": "low",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.33,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.75
        },
        "graph_signals": {
          "support_weight": 0.85,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "针对IL-12/23的作用"
          ],
          "safety_risk": [
            "如若风险成立，将抵消效益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H10",
        "score": 0.24,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.85
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "靶向肠道特异性强调"
          ],
          "safety_risk": [
            "如若风险成立，将抵消效益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H11",
        "score": 0.2,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.85
        },
        "graph_signals": {
          "support_weight": 0.75,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "JAK抑制剂在免疫过程中的潜在应用"
          ],
          "safety_risk": [
            "如若风险成立，将抵消效益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H12",
        "score": 0.2,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.5,
          "safety_risk": 0.3,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.85
        },
        "graph_signals": {
          "support_weight": 0.6,
          "contradiction_weight": 1.7,
          "mechanistic_connectivity": true,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "影响肠道微生物与炎症"
          ],
          "safety_risk": [
            "如若风险成立，将抵消效益"
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      }
    ],
    "ranking": [
      "H6",
      "H7",
      "H9",
      "H1",
      "H2",
      "H3",
      "H4",
      "H5",
      "H10",
      "H11",
      "H12",
      "H8"
    ],
    "delta_since_last_round": 0.33,
    "stop_decision": {
      "should_stop": false,
      "reasons": [
        "Δscore≥0.03"
      ]
    }
  }
}